Drugs / INCA036978
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07441694 | May 2026 → May 2030 expected | myeloproliferative neoplasm | Incyte Corporation | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | INCA036978 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07441694 ↗ |